𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

✍ Scribed by Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincenzo Pasceri; Andrea D'Ambrosio; Antonio Montinaro; Germano Di Sciascio


Book ID
113448294
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
811 KB
Volume
108
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.